February 14th 2025
The company’s Mourenx plant in Southwest France aims to become an API network hub, with first supplies expected by next year.
February 12th 2025
The facilities are expected to offer pharma shipment support by addressing time and temperature-specific requirements.
February 4th 2025
A report offers a comprehensive benchmarking and assessment of pharmaceutical manufacturer engagement with specialty pharmacies.
January 29th 2025
The 7,000 square-foot GMP facility will provide formulation development support, along with analytical testing services.
January 14th 2025
The license agreement will feature an upcoming Phase III trial and—depending on results—the development, manufacturing, and commercialization of evenamide as a potential treatment option.
GSK, Sanofi, and Takeda Partner with Singapore on Biologics Innovation
Big Pharma to collaborate with researchers from A*STAR, along with Singapore universities
WuXi STA Unveils New Parenteral Formulation Manufacturing Line
Will further boost CDMO’s injectable drug product platform
Schreiner MediPharm, SCHOTT Introduce Prefilled Syringes Powered by RFID Labels
Can help facilitate digital identification of medications
MilliporeSigma Commits $286 Million toward US Biosafety Testing
Drug safety analysis to be conducted at Rockland, MD facility
WuXi Vaccines to Debut New Vaccines Facility in China
Plant will be CDMO’s first standalone GMP and vaccine development manufacturing site in the country
BioNTech Establishes APAC Regional Headquarters
Former Novartis plant will become mRNA manufacturing facility, the first in Singapore
Charles River Grows Memphis Facility
Manufacturing plant addition features nine new processing suites
BIOVECTRA Increases Manufacturing Services
New microbial fermentation tech expected to boost CDMO’s overall capacity
Recipharm Invests in BFS Technology
Kaysersberg facility’s Lab+ deal expected to bolster CDMO’s filling services
Stevanato Group, DWK Life Sciences Sign Packaging Platform Agreement
Non-exclusive deal intends to popularize RTU containment solutions within pharma industry
Quotient Sciences Grows Its Drug Substance Manufacturing Facility
Center implements Industry 4.0 principles
Micro-Sphere Furthers Its GMP Services at Swiss Facility
Invests $5 million to upgrade manufacturing processes
Andelyn Biosciences Opens Ohio CGT Manufacturing Facility
ACC supports both clinical and commercial viral vector production
Catalent Increases Biologics Analytical Capabilities, Adds New Laboratories
Expansion project addresses assay development demands
USP Increases Support for Medicine Impurity Analysis
Organization’s PAI portfolio boosts drug R&D, process development for pharma manufacturers
Quotient Sciences Finishes Expansion of Alnwick Facility
Project is centered around drug substance manufacturing
Samsung Biologics Introduces Latest Production Plant
P4 is partially operational in under two years
Building a Robust Cold Chain for CGTs
Strategies to boost the reproducibility and traceability of cell and gene therapies for more effective clinical studies and commercialization
‘Old School,’ New Technology
A conversation with dangerous goods expert Jay Johnson
FDA Approves Kite’s New Viral Vector Manufacturing Facility
Biopharma company's 100,000 square-foot California center will house its blood cancer treatments
Samsung Biologics Awarded Gold EcoVadis Rating
Designation is powered by CDMO’s sustainability focus
Fujifilm Commences Billingham Campus Expansion Project
Microbial production site’s manufacturing capacity to increase by 70% upon completion
MeiraGTx Unveils Gene Therapy Site in Ireland
Commercial GMP facility is first of its kind in the Emerald Isle, the company says
AmerisourceBergen Acquires PharmaLex for $1.28 Billion
With deal, drug wholesaler grows its biopharma services platform
Supply Chain Shortages: Impact on Product Labeling, Artwork, and Packaging
Supply chain shortages mean short notice changes to products—is your labeling system missing the key ingredients?
Bora Completes Deal for TWi Pharmaceuticals
Acquisition helps grow its CDMO capabilities
MilliporeSigma Invests over $131 Million toward French Manufacturing Services
Financial commitment expected to benefit capabilities of single-use assemblies
Barnes & Thornburg Expands East Coast Presence
Law firm to feature life sciences practice in New Jersey and Philadelphia
Gerresheimer AG, Stevanato Group Develop RTU Vial Platform
Among goals, product aims to mitigate supply chain risk for pharma and biotech industries
Lonza, Touchlight Ink mRNA Deal
Allows CDMO to enhance its therapeutic and vaccine offerings